Total Payments
$9,115
2024 Payments
$778.23
Companies
23
Transactions
258
Medicare Patients
1,713
Medicare Billing
$108,648
Payment Breakdown by Category
Food & Beverage$8,668 (95.1%)
Education$447.04 (4.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,668 | 234 | 95.1% |
| Education | $447.04 | 23 | 4.9% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
General
$9,115
257 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,593 | 57 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,486 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,360 | 68 | $0 (2024) |
| Abbott Laboratories | $1,113 | 11 | $0 (2024) |
| ABIOMED | $566.82 | 4 | $0 (2023) |
| PFIZER INC. | $457.25 | 10 | $0 (2024) |
| Medtronic Vascular, Inc. | $421.94 | 2 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $395.12 | 22 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $283.02 | 11 | $0 (2019) |
| BOSTON SCIENTIFIC CORPORATION | $273.55 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $778.23 | 22 | Abbott Laboratories ($262.31) |
| 2023 | $753.41 | 16 | Abbott Laboratories ($289.48) |
| 2022 | $756.28 | 19 | Amgen Inc. ($243.53) |
| 2021 | $295.88 | 10 | AstraZeneca Pharmaceuticals LP ($143.11) |
| 2020 | $766.49 | 17 | Medtronic Vascular, Inc. ($209.34) |
| 2019 | $2,192 | 74 | Amgen Inc. ($530.15) |
| 2018 | $1,700 | 52 | Novartis Pharmaceuticals Corporation ($471.53) |
| 2017 | $1,873 | 48 | Abbott Laboratories ($403.99) |
All Payment Transactions
258 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $149.54 | General |
| Category: Structural Heart | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Cardio-renal | ||||||
| 09/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Education | In-kind items and services | $19.62 | General |
| Category: Cardio-renal | ||||||
| 09/10/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Not Applicable | ||||||
| 09/09/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/06/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: Not Applicable | ||||||
| 08/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/05/2024 | Abbott Laboratories | PRESSUREWIRE (Device) | Food and Beverage | In-kind items and services | $112.77 | General |
| Category: Vascular | ||||||
| 06/11/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $36.47 | General |
| Category: Not Applicable | ||||||
| 06/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Cardio-renal | ||||||
| 06/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/27/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Cardiology | ||||||
| 03/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Education | In-kind items and services | $19.62 | General |
| Category: Cardio-renal | ||||||
| 02/07/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/30/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 01/23/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 2024 | Provisio Medical, Inc. | — | — | — | $0.00 | Ownership |
| 12/19/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Diabetes | ||||||
| 11/15/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $141.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 576 | 598 | $147,112 | $31,958 |
| 2022 | 4 | 415 | 425 | $110,352 | $25,515 |
| 2021 | 6 | 379 | 394 | $195,220 | $26,658 |
| 2020 | 8 | 343 | 369 | $169,402 | $24,517 |
Total Patients
1,713
Total Services
1,786
Medicare Billing
$108,648
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 383 | 395 | $98,750 | $22,487 | 22.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 22 | 22 | $20,460 | $3,949 | 19.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 21 | $9,030 | $2,152 | 23.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 21 | 21 | $9,870 | $1,978 | 20.0% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 46 | 46 | $4,922 | $469.80 | 9.5% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 26 | 26 | $1,820 | $406.64 | 22.3% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 14 | 15 | $1,500 | $331.20 | 22.1% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 40 | 40 | $400.00 | $106.80 | 26.7% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 12 | 12 | $360.00 | $77.28 | 21.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 334 | 344 | $86,000 | $20,946 | 24.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 22 | 22 | $20,460 | $4,014 | 19.6% |
| 93356 | Heart muscle strain imaging | Facility | 2022 | 26 | 26 | $2,782 | $289.93 | 10.4% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2022 | 13 | 13 | $910.00 | $210.14 | 23.1% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2022 | 20 | 20 | $200.00 | $54.69 | 27.3% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 269 | 274 | $147,560 | $17,036 | 11.5% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 32 | 32 | $29,760 | $6,324 | 21.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 23 | $9,890 | $2,645 | 26.7% |
| 93308 | Follow-up or limited ultrasound examination of heart | Facility | 2021 | 12 | 12 | $2,840 | $277.80 | 9.8% |
| 93320 | Doppler ultrasound study of heart blood flow, valves, and chambers | Facility | 2021 | 15 | 15 | $1,050 | $229.46 | 21.9% |
| 93321 | Follow-up or limited heart doppler ultrasound study of heart blood flow, valves, and chambers | Facility | 2021 | 11 | 11 | $570.00 | $74.36 | 13.0% |
| 93325 | Doppler ultrasound study of color-directed heart blood flow, rate, and valve function | Facility | 2021 | 27 | 27 | $3,550 | $72.28 | 2.0% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2020 | 202 | 204 | $108,570 | $13,317 | 12.3% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 31 | 31 | $28,830 | $5,788 | 20.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 19 | 31 | $13,330 | $2,871 | 21.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 13 | 17 | $2,902 | $1,549 | 53.4% |
About Dr. Vivian Abascal, MD
Dr. Vivian Abascal, MD is a Cardiovascular Disease healthcare provider based in Richmond Hill, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1326049909.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vivian Abascal, MD has received a total of $9,115 in payments from pharmaceutical and medical device companies, with $778.23 received in 2024. These payments were reported across 258 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($8,668).
As a Medicare-enrolled provider, Abascal has provided services to 1,713 Medicare beneficiaries, totaling 1,786 services with total Medicare billing of $108,648. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Richmond Hill, NY
- Active Since 08/09/2005
- Last Updated 11/03/2014
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326049909
Products in Payments
- ENTRESTO (Drug) $1,324
- Repatha (Biological) $859.40
- BRILINTA (Drug) $635.13
- Impella (Device) $566.82
- ELIQUIS (Drug) $492.56
- Corlanor (Drug) $481.43
- CoreValve Evolut (Device) $421.94
- PRESSUREWIRE (Device) $402.25
- FARXIGA (Drug) $321.61
- JARDIANCE (Drug) $309.38
- PRALUENT (Drug) $283.02
- Mitra Clip system (Device) $277.19
- GENERAL - STENTS (Device) $258.04
- Coronary Orbital Atherectomy System (Device) $249.83
- XARELTO (Drug) $211.51
- WAINUA (Drug) $153.52
- Absorb GT1 (Device) $141.91
- ANDEXXA (Biological) $125.00
- PRALUENT ALIROCUMAB INJECTION (Biological) $99.97
- Xience Alpine cornary stent system (Device) $90.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Richmond Hill
Dr. Aditya Mangla, D.o, D.O
Cardiovascular Disease — Payments: $77,431
Cardiovascular Disease $77,431
Dr. Jaideep Reddy, M.d, M.D
Cardiovascular Disease — Payments: $28,578
Cardiovascular Disease $28,578
Dr. David Schechter, M.d., F.a.c.c., P.c, M.D., F.A.C.C., P.C
Cardiovascular Disease — Payments: $9,569
Cardiovascular Disease $9,569
Dr. Arun Mangla, Md, MD
Cardiovascular Disease — Payments: $3,244
Cardiovascular Disease $3,244
Dr. Daniel Deckler, Md, MD
Cardiovascular Disease — Payments: $13.08
Cardiovascular Disease $13.08
Amtul Mansoor, Md, MD
Cardiovascular Disease
Cardiovascular Disease